How to accelerate the endothelialization of stents

Archives des Maladies du Coeur et des Vaisseaux

Volumn 98, Issue 2, 2005, Pages 123-126

  Ong, A T L ^a   Aoki, J ^a   Kutryk, M J ^b   Serruys, P W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PACLITAXEL; RAPAMYCIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL ADHESION; CELL DAMAGE; CELL MIGRATION; CELL REGENERATION; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EXERCISE; HOMEOSTASIS; HUMAN; HYPERPLASIA; INFLAMMATION; NONHUMAN; REVIEW; STEM CELL; THROMBOSIS; ANIMAL; METABOLISM; STENT; TISSUE ENGINEERING; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STENTS; TISSUE ENGINEERING;

EID: 18344378624     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994 ; 331 : 489-95.
2. Holmes DR Jr, Savage M, LaBlanche JM et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002 ; 106 : 1243-50.
3. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996 ; 98 : 2277-83.
4. Axel DI, Kunert W, Goggelmann C et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997 ; 96 : 636-45.
5. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003 ; 108 : 2054-9.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 ; 340 : 115-26.
7. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002 ; 105 : 2974-80.
8. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003 ; 23 : 1185-9.
9. Moses JW, Leon MB et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 ; 349 : 1315-23.
10. Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 ; 350 : 221-31.
11. Farb A, Heller PF, Shroff S et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001 ; 104 : 473-9.
12. Guba M, von Breitenbuch P, Steinbauer M et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002 ; 8 : 128-35.
13. Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation 2003 ; 107 : 2635-7.
14. Ross R. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am J Pathol 1993 ; 143 : 987-1002.
15. Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from bioloqy to treatment. Trends Cardiovasc Med 2002 ; 12 : 88-96.
16. Asahara T, Murohara T, Sullivan A et al. Isolation of putative proqenitor endothelial cells for angiogenesis. Science 1997 ; 275 : 964-7.
17. Bhattacharya V, McSweeney PA, Shi Q et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000 ; 95 : 581-5.
18. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000 ; 105 : 1527-36.
19. Hibbert B, Olsen S, O'Brien E. Involvement of progenitor cells in vascular repair. Trends Cardiovasc Med 2003 ; 13 : 322-6.
20. Rafii S, Heissig B, Hottori K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressina anaioqenic factors. Gene Ther 2002 ; 9 : 631-41.
21. Walter DH, Rittig K, Bahlmann FH et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002 ; 105 : 3017-24.
22. Werner N, Priller J, Laufs U et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002 ; 22 : 1567-72.
23. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 ; 348 : 593-600.
24. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999 ; 5 : 434-8.
25. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 ; 103 : 2776-9.
26. Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001 ; 88 : 167-74.
27. Llevadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001 ; 108 : 399-405.
28. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 ; 103 : 2885-90.
29. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 ; 108 : 391-7.
30. Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004 ; 109 : 220-6.
31. Werner N, Junk S, Laufs U et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003 ; 93 : 17-24.
32. Strehlow K, Werner N, Berweiler J et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003 ; 107 : 3059-65.
33. Asahara T, Bauters C, Pastore C et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation 1995 ; 91 : 2793-801.
34. Cho HJ, Kim HS, Lee MM et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor decelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003 ; 108 : 2918-25.
35. van der Giessen WJ, Serruys PW, Visser WJ, Verdouw PD, van Schalkwijk WP, Jongkind JF. Endothelialization of Intravascular Stents. J Invasive Cardiol 1988 ; 1 : 109-20.
36. Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003 ; 24 : 2295-302.